经股动脉TAVR的性别差异:全球多中心回顾性分析
该研究基于2007至2018年全球12,381例经股动脉TAVR患者数据,比较女性与男性的基线特征及结局。女性高血压和肾功能不全比例更高,30天卒中与死亡率无显著差异,但危及生命或大出血风险高50%。男性死亡率下降幅度大于女性。
要点
- 女性TAVR后30天卒中与死亡率与男性相当。
- 女性危及生命或大出血风险较男性高50%。
- 2007至2018年男性死亡率降幅大于女性。
核心结论
- 女性与男性经股动脉TAVR后30天死亡率和卒中率相似,但女性危及生命或大出血发生率更高。
- 2007至2018年间男性死亡率下降幅度大于女性,卒中率无随时间下降。
研究设计与样本
- CENTER协作的全球患者水平回顾性数据集,纳入2007至2018年经股动脉TAVR患者共12,381例。
- 女性占58%(n=7,120),男性占42%(n=5,261)。
- 比较两性基线特征、30天卒中与死亡率及院内结局,并分析结局的时间趋势和性别特异性死亡预测因素。
主要发现
- 女性高血压和肾小球滤过率<30 ml/min/1.73 m2的患病率高于男性,其他传统心血管合并症患病率较低。
- 30天卒中率女性2.3% vs 男性2.5%(p=0.53),30天死亡率女性5.9% vs 男性5.5%(p=0.17)。
- 危及生命或大出血发生率女性6.7% vs 男性4.4%(p<0.01),女性风险高50%。
- 研究期间男性死亡率降低60%,女性降低50%(均p<0.001);卒中率无随时间下降。
临床怎么用
- 经股动脉TAVR围术期应特别关注女性患者的出血风险。
- 女性与男性TAVR后30天卒中与死亡风险相似,性别不应作为排斥TAVR的依据。
局限性
- 为回顾性分析,可能存在残余混杂。
- 仅纳入经股动脉入路患者,结论不能外推至其他入路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transfemoral aortic valve replacement (TAVR) is a guideline-recommended treatment option for patients with severe aortic valve stenosis. Women and men present with different baseline characteristics, which may influence procedural outcomes. OBJECTIVES: This study sought to evaluate differences between women and men undergoing transfemoral TAVR across the globe during the last decade. METHODS: The CENTER (Cerebrovascular EveNts in patients undergoing TranscathetER aortic valve implantation with balloon-expandable valves versus self-expandable valves)-collaboration was a global patient level dataset of patients undergoing transfemoral TAVR (N = 12,381) from 2007 to 2018. In this retrospective analysis, the study examined differences in baseline patient characteristics, 30-day stroke and mortality, and in-hospital outcomes between female and male patients. The study also assessed for temporal changes in outcomes and predictors for mortality per sex. RESULTS: We included 58% (n = 7,120) female and 42% (n = 5,261) male patients. Women had higher prevalence of hypertension and glomerular filtration rate <30 ml/min/1.73 m2 but lower prevalence of all other traditional cardiovascular comorbidities. Both sexes had similar rates of 30-day stroke (2.3% vs. 2.5%; p = 0.53) and mortality (5.9% vs. 5.5%; p = 0.17). In contrast, women had a 50% higher risk of life-threatening or major bleeding (6.7% vs. 4.4%; p < 0.01). Over the study period, mortality rates decreased to a greater extent in men than in women (60% vs. 50% reduction; both p < 0.001), with no reductions in stroke rates over time. CONCLUSIONS: In this global collaboration, women and men had similar rates of 30-day mortality and stroke. However, women had higher rates of procedural life-threatening or major bleeding after TAVR. Between 2007 and 2018, mortality rates decreased to a greater extent in men than in women.
引用
- Vlastra W, Chandrasekhar J, García Del Blanco B, et al. Sex Differences in Transfemoral Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2019. PMID: 31562908. doi:10.1016/j.jacc.2019.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。